Global Auto Injectors Market Segmentation, By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies), Type (Disposable Auto injectors, Reusable Auto Injectors), End- User (Home Care Settings, Hospitals and Clinics, Ambulatory Surgical Centers), Route of administration (Subcutaneous, Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Design (Standardized, Customized), Product (Prefilled, Fillable) – Industry Trends and Forecast to 2031
Auto Injectors Market Analysis
Auto injectors are utilized for epinephrine self-administration in order to prevent anaphylaxis, for immediate pain relief by migraine sufferers and for medical and emergency treatments. The rise in incidence of anaphylaxis is escalating the growth of auto injectors market.
Auto Injectors Market Size
Global auto injectors market size was valued at USD 83.05 billion in 2023 and is projected to reach USD 401.48 billion by 2031, with a CAGR of 21.77% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Auto Injectors Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
AbbVie Inc. (US), Mylan N.V. (US), Lily. (US), Amgen Inc. (US), Ypsomed Holding (Switzerland), BD (US), Owen Mumford Ltd. (UK), Consort Medical, Plc. (UK), SHL Medical AG (Switzerland), Johnson Medtech, LLC. (US), Teva Pharmaceuticals USA, Inc. (US), Antares Pharma. (New Jersey), AstraZeneca (UK), Union Medico Inc. (Denmark), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc (US), and Emergent. (US), among others
|
Auto Injectors Market Definition
An auto injector refers to a syringe with a spring-charged needle that has a pre-charged dosage of drugs. A measured dosage of a drug is triggered and administered when pressed into the body with a sliding motion. Auto-injectors offer various advantages such as, reducing needle-related phobia disorder, and risks of needle stuck accidents, among others.
Auto Injectors Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Prevalence of Targeted Therapies
The increase in the prevalence of targeted therapies, such as alemtuzumab (certain chronic leukemias), and trastuzumab (certain breast cancers), among others acts as one of the major factors driving the growth of auto injectors market.
- Funds and Grants
The surge in investments in the form of funds and grants for therapies associated with auto injectors accelerate the market growth.
- Favorable reimbursements
The presence of favorable reimbursements and increasing government support further influence the auto injectors market.
Opportunities
Furthermore, patent expiry of biologics to drive the demand for biosimilars extend profitable opportunities to the market players in the forecast period of 2024 to 2031. Also, increasing the preference for self-administration will further expand the auto injectors market.
Restraints/Challenges Global Auto Injectors Market
On the other hand, increase in the preference for alternative drug delivery modes and development of nasal epinephrine sprays are expected to obstruct market growth. Also, development of autoinjectors for multiple drug viscosities and lack of proper training for using auto injectors are projected to challenge the auto injectors market in the forecast period of 2024-2031.
This auto injectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on auto injectors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Auto Injectors Market Scope
The auto injectors market is segmented on the basis of therapy, type, end- users, route of administration, molecule, design and product. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Therapy
- Rheumatoid Arthritis
- Multiple Sclerosis
- Diabetes
- Anaphylaxis
- Other Therapies
Type
- Disposable Auto Injectors
- Reusable Auto Injectors
End- Users
- Home Care Settings
- Hospitals and Clinics
- Ambulatory Surgical Centers
Route of Administration
- Subcutaneous
- Intramuscular
Type of Molecule
- Monoclonal Antibody
- Peptide
- Protein
- Small Molecule
Design
- Standardized
- Customized
Product
- Prefilled
- Fillable
Auto Injectors Market Regional Analysis
The auto injector market is analysed and market size insights and trends are provided by country, therapy, type, end- users, route of administration, type of molecule, design and product as referenced above.
The countries covered in the auto injector market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the auto injector market because of the advancements in medical devices technologies and advanced healthcare infrastructure within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increasing incidence of diabetics and anaphylaxis due to food allergies in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The auto injector market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for auto injector market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the auto injector market. The data is available for historic period 2010-2020.
Auto Injectors Market Share
The auto injector market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to auto injector market.
Auto Injectors Market Leaders Operating in the Market Are:
- AbbVie Inc. (US)
- Mylan N.V. (US)
- Lily. (US)
- Amgen Inc. (US)
- Ypsomed Holding (Switzerland)
- BD (US)
- Owen Mumford Ltd. (UK)
- Consort Medical, Plc. (UK)
- SHL Medical AG (Switzerland)
- Johnson Medtech, LLC. (US)
- Teva Pharmaceuticals USA, Inc. (US)
- Antares Pharma. (New Jersey)
- AstraZeneca (UK)
- Union Medico Inc. (Denmark)
- Gerresheimer AG (Germany)
- West Pharmaceutical Services, Inc (US)
- Emergent. (US)
Latest Developments in Auto Injectors Market
- Antares Pharma (US) made an agreement with Lunatus Global Medical Supplies (Dubai) in August’2020. Antares is expected to supply packaged products to Lunatus according to the agreement. Lunatus will submit and obtain regulatory approval for XYOSTED in the UAE and Saudi Arabia, and will promote, market and distribute XYOSTED in these two countries
SKU-